back to Physicians List
Dr. Shaffer joined NGOC in 1997 after 16 years of service in the United States Army where he received his fellowship training at Brooke Army Medical Center. He is Board Certified in Internal Medicine, Medical Oncology, and Hematology and sees patients at the Marietta and Jasper offices. Dr. Shaffer leads an active life with his four children.
DON W. SHAFFER II, M.D., F.A.C.P.
OFFICE ADDRESS NORTHWEST GEORGIA ONCOLOGY CENTERS, P.C.
MARIETTA OFFICE
340 Kennestone Hospital Blvd., Suite 200
Marietta, GA 30060
Phone: (770) 281-5100 Fax: (678) 581-7100

JASPER OFFICE
620 J.L. White Drive, Suite 140
Jasper, GA 30143
706-692-9016
PERSONAL DATA Birthplace: Fort Meade, MD
UNDERGRADUATE EDUCATION BS, Microbiology (summa cum laude), 1978
University of Central Florida
MEDICAL EDUCATION Doctor of Medicine
University of Miami School of Medicine
Miami, FL
1978 – 1982
POSTDOCTORAL TRAINING INTERNSHIP AND RESIDENCY
Categorical Medicine
Madigan Army Medical Center
Tacoma, WA
July 1982 – June 1985

FELLOWSHIP
Hematology & Medical Oncology
Brooke Army Medical Center
Fort Sam Houston, TX
July 1989 – June 1992
BOARD CERTIFICATION American Board of Internal Medicine, Internal Medicine 1985
American Board of Internal Medicine, Medical Oncology 1991
American Board of Internal Medicine, Hematology 1992
MEDICAL LICENSURE State of Georgia, 1992 (Active)
PROFESSIONAL SOCIETIES

American College of Physicians, 1982 – Present
American College of Physicians, 1993 - Present
Cobb County Medical Society, 1997 - Present
Medical Association of Georgia, 1995 – Present
American Society of Clinical Oncology, 1993 - Present
Georgia Society of Clinical Oncology, 1999 - Present
American Medical Association, 1995 – Present
Southwest Oncology Group, 1993 - Present
Christian Medical Dental Society, 1979 – Present
Berlin Int’l Medical Society, 1985 – 1989
Instructor, American Heart Association, 1985 – 1997
Affiliate Faculty, American Heart Association, 1989 – 1997
Cancer and Leukemia Group B, 1994 – 1997
ACADEMIC APPOINTMENTS Commissioned, USAR, May 1978
Promotion to Captain, June 1982
Promotion to Major, June 1988
Promotion to Lt. Colonel, June 1994
ETS, September 1994
PROFESSIONAL EXPERIENCE

Associate Clinical Professor, Division of Hematology Oncology, Medical College of Georgia 1993 – 1994
PUBLICATIONS ARTICLES:
Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD. Preoperative therapy with concurrent Paclitaxel/ Carboplatin/ Infusional 5-FU and radiation therapy in Locoregional Esophageal Cancer: Final results of Minnie Pearl Cancer Research Network Phase II Trial. Cancer J 9:251-260, 2003.

Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S, Yardley DA, Burris HA, Morrissey LH, Erland JB, Hainsworth JD:  Carcinoma of Unknown primary site: Sequential treatment with Paclitaxel/ Carboplatin/ Etoposide and Gemcitabine/ Irinotecan:  A Minnie Pearl Cancer Research Network Phase II trial.  ASCO 2004.  Submitted.

Hainsworth JD, Litchy S, Shaffer DW, Lackey VL, Grimaldi M, Greco FA:   Maximizing Therapeutic Benefit of Rituximab:   Maintenance Therapy Versus Re-Treatment at Progression in Patients with Indolent Non-Hodgkin’s Lymphoma - A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network.  Journal of Clinical Oncology 23:1088-1095, 2005. 

ABSTRACTS:
McKay CE, III, Hainsworth JD, Burris HA, Yardley DA, Sarah Cannon Cancer Center/ Tennessee Oncology, PLLC, Nashville, TN, Litchy S, Erland JB, Stagg MP, Hon JK, Shaffer DW, Greco FA. Treatment of metastatic poorly differentiated neuroendocrine (PDNE) carcinoma with paclitaxel/ carboplatin/ etoposide (PCE): A Minnie Pearl Cancer Research Network Phase II Trial. ASCO 21:630, 2002

Hainsworth JD, Gray JR, Litchy S, Shaffer DW, Houston GA, Bearden JD, Greco FA: A Minnie Pearl Cancer Research Network: Preoperative concurrent radiation therapy (RT) and weekly Paclitaxel/ Carboplatin for patients with locally advanced non-small lung cancer (NSCLC). ASCO 2003. Submitted.

Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S, Yardley DA, Burris HA, Morrissey LH, Erland JB, Hainsworth JD: Carcinoma of Unknown primary site: Sequential treatment with Paclitaxel/ Carboplatin/ Etoposide and Gemcitabine/ Irinotecan: A Minnie Pearl Cancer Research Network Phase II trial. ASCO 2004. Submitted
MAJOR RESEARCH INTERESTS Clinical Trials (Oncology & Hematology)
For a listing of the Active Clinical Trials that NGOC participates in, click here
Use your browser's "back" button to return to this physician's page

NEWS, EVENTS & ACTIVITIES | WILLIAM S. GIBBONS CANCER RESEARCH INSTITUTE | SEARCH-THE-SITE